- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.02. | CHINA HEALTH (00673): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES | - | HKEx | ||
| 26.02. | CHINA HEALTH (00673): COMPLETION OF SUBSCRIPTION FOR NEW SHARES UNDER GENERAL MANDATE | - | HKEx | ||
| 13.02. | CHINA HEALTH (00673): CANCELLATION OF SHARE OPTIONS | 3 | HKEx | ||
| 02.02. | CHINA HEALTH (00673): SUBSCRIPTION FOR NEW SHARES TO BE ISSUED UNDER THE GENERAL MANDATE | - | HKEx | ||
| 02.02. | CHINA HEALTH (00673): GRANT OF SHARE OPTIONS | 1 | HKEx | ||
| CHINA HEALTH GROUP LTD Aktie jetzt für 0€ handeln | |||||
| 23.01. | CHINA HEALTH (00673): UPDATE IN RELATION TO THE DISCLAIMER OF OPINION ON GOING CONCERN SET OUT IN THE ANNUAL REPORT FOR THE YEAR ENDED 31 MARCH 2025 | 1 | HKEx | ||
| 22.12.25 | CHINA HEALTH (00673): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS | 1 | HKEx | ||
| 22.12.25 | CHINA HEALTH (00673): NOTIFICATION LETTER AND REPLY FORM FOR REGISTERED SHAREHOLDERS | - | HKEx | ||
| 22.12.25 | CHINA HEALTH (00673): INTERIM REPORT 2025 | - | HKEx | ||
| 28.11.25 | CHINA HEALTH (00673): INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025 | 2 | HKEx | ||
| 28.11.25 | CHINA HEALTH (00673): SUPPLEMENTAL ANNOUNCEMENT TO THE ANNUAL REPORT OF THE COMPANY FOR THE YEAR ENDED 31 MARCH 2025 | 1 | HKEx | ||
| 19.11.25 | CHINA HEALTH (00673): UPDATE IN RELATION TO THE DISCLAIMER OF OPINION ON GOING CONCERN SET OUT IN THE ANNUAL REPORT FOR THE YEAR ENDED 31 MARCH 2025 | - | HKEx | ||
| 18.11.25 | CHINA HEALTH (00673): NOTICE OF BOARD MEETING | - | HKEx | ||
| 31.10.25 | CHINA HEALTH (00673): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | - | HKEx | ||
| 31.10.25 | CHINA HEALTH (00673): (1) CHANGE OF CHAIRMAN OF THE BOARD; (2) CHANGE OF DIRECTORS; AND (3) CHANGE OF COMPOSITION OF BOARD COMMITTEES | - | HKEx | ||
| 06.10.25 | CHINA HEALTH (00673): NEXT DAY DISCLOSURE RETURN - CHANGE IN ISSUED SHARE CAPITAL | - | HKEx | ||
| 06.10.25 | CHINA HEALTH (00673): COMPLETION OF (I) SUBSCRIPTIONS OF NEW SHARES UNDER SPECIFIC MANDATE; AND (II) RIGHTS ISSUE ON THE BASIS OF THREE (3) RIGHTS SHARES ... | 1 | HKEx | ||
| 03.10.25 | CHINA HEALTH (00673): (I) RESULTS OF THE RIGHTS ISSUE ON THE BASIS OF THREE (3) RIGHTS SHARES FOR EVERY TEN (10) SHARES HELD ON THE RECORD DATE; AND (II) ... | 1 | HKEx | ||
| 26.09.25 | CHINA HEALTH (00673): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 SEPTEMBER 2025 | - | HKEx |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 236,10 | +0,58 % | Mark Cuban Calls $30,000 Corporate Healthcare Burden 'Insane,' Backs Bill To Break Up Big Medicine Giants UNH, CVS, CI | ||
| MEDTRONIC | 75,34 | +0,80 % | Medtronic Inks Distribution Agreement With Merit Medical Systems To Offer FDA-approved ViaVerte | DUBLIN (dpa-AFX) - Medical technology company Medtronic plc (MDT) announced Tuesday that it has entered into a distribution agreement with Merit Medical Systems, Inc. (MMSI), to offer FDA-approved... ► Artikel lesen | |
| INTUITIVE SURGICAL | 412,15 | +0,16 % | Intuitive Surgical vs. Stryker: Which Surgical Tech Stock Leads? | ||
| VERU | 2,290 | -0,43 % | Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients... ► Artikel lesen | |
| ONWARD MEDICAL | 3,500 | -0,57 % | ONWARD Medical NV: ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update | EINDHOVEN, the Netherlands, March 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,000 | +0,79 % | EQS-DD: Siemens Healthineers AG: Dorothea Simon, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
20.03.2026 / 16:23... ► Artikel lesen | |
| ENVUE MEDICAL | 2,250 | 0,00 % | ENvue Medical Shares Jump 45% After Hospital Platform Expansion | ||
| FRESENIUS | 44,710 | +1,22 % | PRESSESPIEGEL/Unternehmen: COMMERZBANK, DEUTSCHE BANK, FRESENIUS, DEUTSCHE BAHN | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
COMMERZBANK - Der Commerzbank-Betriebsrat verschärft im Übernahmekampf... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,310 | +0,98 % | EQS-DD: Fresenius Medical Care AG: Helen Pring Giza, Kauf von Aktien unter dem Fresenius Medical Care Management Board Long Term Incentive Plan 2020 (Zuteilung 2023) | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
18.03.2026 / 09:28... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 43,330 | 0,00 % | Leerink reiterates Outperform on BrightSpring Health stock after investor day | ||
| HEARTFLOW | 27,960 | 0,00 % | Heartflow stock price target raised to $43 by Canaccord on guidance | ||
| ALIGNMENT HEALTHCARE | 17,410 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| GENEDX | 68,70 | 0,00 % | Craig-Hallum Reaffirms Buy on GeneDx (WGS) With $153 Price Target | ||
| TALKSPACE | 5,125 | -0,39 % | Universal Health Services, Inc. to Acquire Talkspace, Inc. | Industry-leading virtual behavioral healthcare platform accelerates outpatient strategy with expanded access to care KING OF PRUSSIA, Pa. and NEW YORK, March 9, 2026 /PRNewswire/ -- Universal... ► Artikel lesen | |
| ADAPTHEALTH | 11,460 | 0,00 % | Leerink cuts AdaptHealth stock price target on 2025 earnings decline |
CHINA HEALTH GROUP LTD gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHINA HEALTH GROUP LTD finden Sie auf Wallstreet Online.